Fiscal year 2024 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses MASI in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named MASI in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Joe Kiani | $1,209,181 | $0 | $10,259,983 | $3,420,105 | $0 | $0 | $1,043,076 | $15,932,345 |
| Former Chief Executive Officer and Chairman of the Board | ||||||||
| Bilal Muhsin | 655,119 | 0 | 5,932,128 | 712,487 | 870,426 | — | 10,350 | 8,180,510 |
| Chief Operating Officer | ||||||||
| Micah Young | 627,822 | 0 | 5,932,128 | 712,487 | 834,159 | — | 11,850 | 8,118,446 |
| Executive Vice President and Chief Financial Officer | ||||||||
| Tom McClenahan | 524,095 | 0 | 5,932,128 | 712,487 | 0 | — | 10,350 | 7,179,060 |
| Executive Vice President, General Counsel and Corporate Secretary | ||||||||
| Blair Tripodi | 574,285 | 0 | 5,426,674 | 543,991 | 285,000 | — | 22,418 | 6,852,368 |
| Chief Operating Officer, Consumer Division | ||||||||
| Michelle Brennan | 236,454 | 0 | 1,441,093 | 0 | 0 | — | 18,454 | 1,696,001 |
| Former Interim Chief Executive Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2024 total | FY2023 total | FY2022 total | Δ FY2023→2024 |
|---|---|---|---|---|
| Joe Kiani | $15,932,345 | — | $16,219,278 | — |
| Bilal Muhsin | 8,180,510 | — | 3,386,139 | — |
| Micah Young | 8,118,446 | — | 1,973,600 | — |
| Tom McClenahan | 7,179,060 | — | 1,974,317 | — |
| Blair Tripodi | 6,852,368 | — | — | — |
| Michelle Brennan | 1,696,001 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
No insider equity transactions reported since the proxy statement.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Blair Tripodi | OPTION | 2024-03-01 | — | — | 9,127 | — | $543,991 |
| Tom McClenahan | RSU | 2024-03-01 | — | — | 30,000 | — | 3,792,000 |
| Micah Young | OPTION | 2024-03-01 | — | — | 11,954 | — | 712,487 |
| Tom McClenahan | OPTION | 2024-03-01 | — | — | 11,954 | — | 712,487 |
| Micah Young | PSU | 2024-03-01 | 8,449 | 16,898 | — | 33,796 | 2,137,428 |
| Blair Tripodi | PSU | 2024-03-01 | 6,451 | 12,902 | — | 25,804 | 1,631,973 |
| Joe Kiani | OPTION | 2024-03-01 | — | — | 57,382 | — | 3,420,105 |
| Joe Kiani | PSU | 2024-03-01 | 40,557 | 81,113 | — | 162,226 | 10,259,983 |
| Tom McClenahan | PSU | 2024-03-01 | 8,449 | 16,898 | — | 33,796 | 2,137,428 |
| Bilal Muhsin | PSU | 2024-03-01 | 8,449 | 16,898 | — | 33,796 | 2,137,428 |
| Bilal Muhsin | RSU | 2024-03-01 | — | — | 30,000 | — | 3,792,000 |
| Michelle Brennan | RSU | 2024-11-11 | — | — | 8,916 | — | 1,441,093 |
| Blair Tripodi | RSU | 2024-03-01 | — | — | 30,000 | — | 3,792,000 |
| Micah Young | RSU | 2024-03-01 | — | — | 30,000 | — | 3,794,700 |
| Bilal Muhsin | OPTION | 2024-03-01 | — | — | 11,954 | — | 712,487 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Blair Tripodi | $3,792,000 | $1,631,973 | $543,991 | 27.3% |
| Tom McClenahan | 3,792,000 | 2,137,428 | 712,487 | 32.2% |
| Micah Young | 3,794,700 | 2,137,428 | 712,487 | 32.2% |
| Joe Kiani | 0 | 10,259,983 | 3,420,105 | 75.0% |
| Bilal Muhsin | 3,792,000 | 2,137,428 | 712,487 | 32.2% |
| Michelle Brennan | 1,441,093 | 0 | 0 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Micah Young | PSU | 11,305 | — | $1,932,816 |
| Tom McClenahan | Option | 1,583 | 250.73 | — |
| Tom McClenahan | PSU | 6,284 | — | 1,074,375 |
| Bilal Muhsin | Option | 7,042 | 182.43 | — |
| Bilal Muhsin | PSU | 16,898 | — | 2,889,051 |
| Bilal Muhsin | Option | 11,954 | 126.49 | — |
| Micah Young | RSU | 30,000 | — | 5,129,100 |
| Tom McClenahan | Option | 7,042 | 182.43 | — |
| Tom McClenahan | PSU | 11,305 | — | 1,932,816 |
| Micah Young | PSU | 6,284 | — | 1,074,375 |
| Tom McClenahan | Option | 3,818 | 157.53 | — |
| Micah Young | Option | 7,042 | 182.43 | — |
| Bilal Muhsin | Option | 7,635 | 157.53 | — |
| Bilal Muhsin | RSU | 30,000 | — | 5,129,100 |
| Michelle Brennan | RSU | 8,916 | — | 1,524,639 |
| Michelle Brennan | RSU | 1,790 | — | 306,036 |
| Blair Tripodi | Option | 9,127 | 126.49 | — |
| Tom McClenahan | PSU | 16,898 | — | 2,889,051 |
| Micah Young | Option | 1,583 | 250.73 | — |
| Tom McClenahan | Option | 1,327 | 179.42 | — |
| Micah Young | Option | 3,818 | 157.53 | — |
| Bilal Muhsin | Option | 2,654 | 179.42 | — |
| Micah Young | Option | 1,327 | 179.42 | — |
| Blair Tripodi | Option | 5,377 | 182.43 | — |
| Micah Young | Option | 11,954 | 126.49 | — |
| Bilal Muhsin | PSU | 11,305 | — | 1,932,816 |
| Micah Young | PSU | 16,898 | — | 2,889,051 |
| Tom McClenahan | RSU | 30,000 | — | 5,129,100 |
| Blair Tripodi | RSU | 30,000 | — | 5,129,100 |
| Blair Tripodi | PSU | 12,902 | — | 2,205,855 |
| Blair Tripodi | PSU | 8,633 | — | 1,475,984 |
| Tom McClenahan | Option | 11,954 | 126.49 | — |
| Blair Tripodi | PSU | 8,587 | — | 1,468,119 |
| Bilal Muhsin | Option | 3,165 | 250.73 | — |
| Bilal Muhsin | PSU | 12,569 | — | 2,198,503 |
| Blair Tripodi | RSU | 2,576 | — | 440,419 |
The primary objectives of our executive compensation program are to align executive compensation with the long-term interests of our stockholders and to attract and retain a talented, entrepreneurial and creative team of executives who will provide leadership for our success in driving our technologies and products to the broadest number of patients, and in turn, creating sustainable long-term value.
| CEO STI target (% of salary) | 100% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | FW Cook |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2025 | 2025-04-29 | 42,464,598 | 5,711,459 | 717,819 | 88.14% | Passed |
| 2024 | 2024-09-19 | 31,525,446 | 17,074,692 | 149,809 | 64.87% | Passed |
| 2023 | 2023-06-26 | 25,947,310 | 20,662,682 | 672,504 | 55.67% | Passed |
| 2022 | 2022-05-26 | 18,244,967 | 20,238,547 | 355,961 | 47.41% | Failed |
| 2021 | 2021-05-27 | 37,344,204 | 8,950,327 | 93,490 | 80.67% | Passed |
| 2020 | 2020-05-29 | 40,638,880 | 5,737,356 | 288,918 | 87.63% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2025 | 2025-04-29 | 88.14%a |
| 2024 | 2024-09-19 | 64.87%b |
| 2023 | 2023-06-26 | 55.67%c |
a. Approved under the standard stated in the filing — “What is the effect of votes withheld, abstentions and broker non-votes? Abstentions: Under Delaware law (under which Masimo is incorporated), abstentions are counted as shares present and entitled to vote at the Annual Meeting, but they are not counted as shares cast.”.
b. Approved under the standard stated in the filing — “Abstentions: Under Delaware law (under which Masimo is incorporated), abstentions are counted as shares present and entitled to vote at the Annual Meeting, but they are not counted as shares cast.”.
c. Approved under the standard stated in the filing — “What is the effect of abstentions and broker non-votes? Abstentions: Under Delaware law (under which Masimo is incorporated), abstentions are counted as shares present and entitled to vote at the Annual Meeting, but they are not counted as shares cast.”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Ratio (CEO : median employee) | 163 : 1 |
|---|---|
| CEO total compensation | $13,390,142 |
| Median employee compensation | $82,544 |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Robert ChapekIndependent · Audit · Not standing for re-election | $84,339 | $399,963 | $0 | $0 | $0 | $484,302 |
| Craig ReynoldsIndependent · Compensation · Not standing for re-election | 130,411 | 199,997 | 0 | 0 | 0 | 330,408 |
| Quentin KoffeyIndependent · Audit · Compensation · Nominating, Compliance and Corporate Governance (Chair) · Business Risk & Review | 100,892 | 199,997 | 0 | 0 | 0 | 300,889 |
| Michelle BrennanIndependent · Board Chair · Business Risk & Review (Chair) | 77,816 | 199,997 | 0 | 0 | 0 | 277,813 |
| William JellisonIndependent · Audit (Chair) · Compensation · Nominating, Compliance and Corporate Governance · Newly elected | 27,889 | 199,997 | 0 | 0 | 0 | 227,886 |
| Darlene SolomonIndependent · Compensation (Chair) · Nominating, Compliance and Corporate Governance · Business Risk & Review · Newly elected | 26,017 | 199,997 | 0 | 0 | 0 | 226,014 |
| Timothy ScannellIndependent · Compensation · Business Risk & Review · Newly elected | 16,041 | 199,926 | 0 | 0 | 0 | 215,967 |
| Wendy LaneIndependent · Nominating, Compliance and Corporate Governance · Business Risk & Review · Newly elected | 15,247 | 199,926 | 0 | 0 | 0 | 215,173 |
| Rolf ClassonIndependent · Former committee service during 2024 · Departed during FY | 44,792 | 0 | 0 | 0 | 0 | 44,792 |
| Adam MikkelsonIndependent · Former committee service during 2024 · Departed during FY | 18,150 | 0 | 0 | 0 | 0 | 18,150 |
| Catherine SzymanEmployee director · Newly elected | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $70,000 |
|---|---|
| Annual equity retainer | $200,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | — |
| Stock ownership guideline | $350,000 |
| Component | FY2024 |
|---|---|
| Cash retainers and fees | $541,594 |
| Equity awards (grant-date value) | $1,799,800 |
| All other compensation | $0 |
| Total cost of the board | $2,341,394 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies Masimo Corp names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Masimo Corp.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Align Technology, Inc. | 2025 | Joseph Hogan | $1,400,000 | $16,556,872 | $0 | $1,220,100 | $19,193,988 |
| 2 | Insulet Corporation | 2025 | Ashley McEvoy | 729,808 | 12,958,850 | 2,999,913 | 2,031,562 | 18,858,968 |
| 3 | The Cooper Companies | 2025 | Albert White III | 1,170,769 | 6,642,918 | 6,643,050 | 1,525,951 | 16,051,141 |
| 4 | Masimo Corp | 2024 | Joe Kiani | 1,209,181 | 10,259,983 | 3,420,105 | 0 | 15,932,345 |
| 5 | Hologic, Inc. | 2024 | Stephen MacMillan | 1,212,628 | 9,141,468 | 2,937,477 | 1,990,413 | 15,819,261 |
| 6 | ResMed | 2025 | Michael Farrell | 1,214,150 | 8,775,059 | 2,925,007 | 1,646,743 | 14,674,543 |
| 7 | Haemonetics Corp. | 2026 | Christopher Simon | 1,100,008 | 7,561,987 | 1,504,968 | 1,834,250 | 12,044,701 |
| 8 | QuidelOrtho | 2025 | Brian Blaser | 1,000,000 | 8,965,822 | 0 | 1,274,500 | 11,255,782 |
| 9 | Teladoc Health, Inc. | 2025 | Charles Divita, III | 800,000 | 9,699,996 | 0 | 584,000 | 11,202,996 |
| 10 | Integra LifeSciences Holdings Corp. | 2025 | Mojdeh Poul | 1,009,616 | 5,219,868 | 2,250,011 | 174,563 | 9,375,551 |
| 11 | DENTSPLY SIRONA, Inc. | 2025 | Daniel Scavilla | 431,753 | 3,484,488 | 3,221,523 | 437,150 | 8,760,139 |
| 12 | LivaNova PLC | 2025 | Vladimir Makatsaria | 956,115 | 4,303,092 | 1,374,999 | 1,287,656 | 8,047,217 |
| 13 | Dexcom, Inc. | 2025 | Jacob Leach | 768,962 | 5,936,062 | 0 | 1,164,780 | 7,985,960 |
| 14 | Teleflex, Inc. | 2025 | Liam Kelly | 1,144,400 | 2,005,604 | 2,886,518 | 227,280 | 6,732,419 |
| 15 | ICU Medical, Inc. | 2025 | Vivek Jain | 775,000 | 4,500,023 | 0 | 1,162,500 | 6,452,042 |
| 16 | Globus Medical, Inc. | 2025 | Keith Pfeil | 479,467 | 0 | 2,982,347 | 783,000 | 4,400,159 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Masimo Corp | 134% | PSU 75 · Options 25 | Yes — Three-Year Cumulative Relative TSR | FW Cook |
| Align Technology, Inc. | 58.1% | MSU 70 · RSU 30 | Yes — Relative Total Stockholder Return (TSR) vs. Nasdaq Composite Index | Compensia, Inc. |
| DENTSPLY SIRONA, Inc. | 66% | PSU 50 · Options 50 | No | Frederic W. Cook & Co., Inc. |
| Dexcom, Inc. | not disclosed | not disclosed | Yes — Relative TSR Performance Metric | Aon Hewitt Consulting Company |
| Globus Medical, Inc. | 102% | Options 100 | not disclosed | FW Cook |
| Haemonetics Corp. | 133.4% | PSU 60 · RSU 20 · Options 20 | Yes — Relative Total Shareholder Return (rTSR) | Pearl Meyer & Partners, LLC |
| Hologic, Inc. | 109% | PSU 50 · RSU 25 · Options 25 | No | not disclosed |
| ICU Medical, Inc. | 150% | PSU 50 · RSU 50 | No | Compensia |
| Insulet Corporation | 195.8% | PSU 60 · RSU 20 · Options 20 | No | Pearl Meyer & Partners, LLC |
| Integra LifeSciences Holdings Corp. | 40% | PSU 50 · Options 25 · RSU 25 | No | WTW |
| LivaNova PLC | 122.4% | PSU 50 · RSU 25 · Options 25 | No | Pearl Meyer |
| QuidelOrtho | 127% | PSU 60 · RSU 40 | Yes — Total Shareholder Return (TSR) | Compensia |
| ResMed | 102% | PSU 50 · RSU 25 · Options 25 | Yes — Absolute TSR | FW Cook, Inc. |
| Teladoc Health, Inc. | 73% | RSU 50 · PSU 50 | No | Aon |
| Teleflex, Inc. | 25.9% | Options 55 · RSU 25 · PSU 20 | Yes — Absolute TSR | FW Cook |
| The Cooper Companies | 100.9% | Options 50 · PSU 50 | No | Compensia |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Joe Kiani | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “SUMMARY COMPENSATION TABLE” · page 61. As printed: 15,932,345. Filing ↗machine: span 1265493–1265503 |
| 2 | Section 01, Bilal Muhsin | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “SUMMARY COMPENSATION TABLE” · page 61. As printed: 8,180,510. Filing ↗machine: r9 · c41 · span 1310194–1310203 |
| 3 | Section 01, Micah Young | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “SUMMARY COMPENSATION TABLE” · page 61. As printed: 8,118,446. Filing ↗machine: r6 · c41 · span 1293446–1293455 |
| 4 | Section 01, Tom McClenahan | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “SUMMARY COMPENSATION TABLE” · page 61. As printed: 7,179,060. Filing ↗machine: r12 · c41 · span 1326779–1326788 |
| 5 | Section 01, Blair Tripodi | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “SUMMARY COMPENSATION TABLE” · page 61. As printed: 6,852,368. Filing ↗machine: r15 · c41 · span 1343526–1343535 |
| 6 | Section 01, Michelle Brennan | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “SUMMARY COMPENSATION TABLE” · page 61. As printed: 1,696,001. Filing ↗machine: t65 · r5 · c41 · span 1287842–1287851 |
| 7 | Section 03, Blair Tripodi OPTION | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Grants of Plan-Based Awards During Fiscal Year 2024” · grants of plan-based awards table. Filing ↗machine: t62 · r5 · c3 · span 1147256–1147261 |
| 8 | Section 03, Tom McClenahan RSU | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Grants of Plan-Based Awards During Fiscal Year 2024” · grants of plan-based awards table. Filing ↗machine: t66 · r15 · c44 · span 1479462–1479468 |
| 9 | Section 03, Micah Young OPTION | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Grants of Plan-Based Awards During Fiscal Year 2024” · grants of plan-based awards table. Filing ↗machine: t62 · r2 · c3 · span 1142727–1142733 |
| 10 | Section 03, Tom McClenahan OPTION | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Grants of Plan-Based Awards During Fiscal Year 2024” · grants of plan-based awards table. Filing ↗machine: t62 · r4 · c3 · span 1145738–1145744 |
| 11 | Section 03, Micah Young PSU | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Grants of Plan-Based Awards During Fiscal Year 2024” · grants of plan-based awards table. Filing ↗machine: t62 · r2 · c6 · span 1143199–1143205 |
| 12 | Section 03, Blair Tripodi PSU | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Grants of Plan-Based Awards During Fiscal Year 2024” · grants of plan-based awards table. Filing ↗machine: t62 · r5 · c6 · span 1147727–1147733 |
| 13 | Section 03, Joe Kiani OPTION | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Grants of Plan-Based Awards During Fiscal Year 2024” · grants of plan-based awards table. Filing ↗machine: t62 · r1 · c3 · span 1141233–1141239 |
| 14 | Section 03, Joe Kiani PSU | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Grants of Plan-Based Awards During Fiscal Year 2024” · grants of plan-based awards table. Filing ↗machine: t62 · r1 · c6 · span 1141707–1141713 |
| 15 | Section 03, Tom McClenahan PSU | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Grants of Plan-Based Awards During Fiscal Year 2024” · grants of plan-based awards table. Filing ↗machine: t62 · r4 · c6 · span 1146210–1146216 |
| 16 | Section 03, Bilal Muhsin PSU | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Grants of Plan-Based Awards During Fiscal Year 2024” · grants of plan-based awards table. Filing ↗machine: t62 · r3 · c6 · span 1144716–1144722 |
| 17 | Section 03, Bilal Muhsin RSU | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Grants of Plan-Based Awards During Fiscal Year 2024” · grants of plan-based awards table. Filing ↗machine: t66 · r11 · c44 · span 1447570–1447576 |
| 18 | Section 03, Michelle Brennan RSU | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “GRANTS OF PLAN-BASED AWARDS DURING FISCAL YEAR 2024” · grants of plan-based awards table. Filing ↗machine: t66 · r5 · c62 · span 1401825–1401834 |
| 19 | Section 03, Blair Tripodi RSU | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Grants of Plan-Based Awards During Fiscal Year 2024” · grants of plan-based awards table. Filing ↗machine: t66 · r19 · c44 · span 1511353–1511359 |
| 20 | Section 03, Micah Young RSU | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Grants of Plan-Based Awards During Fiscal Year 2024” · grants of plan-based awards table. Filing ↗machine: t66 · r7 · c44 · span 1415680–1415686 |
| 21 | Section 03, Bilal Muhsin OPTION | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Grants of Plan-Based Awards During Fiscal Year 2024” · grants of plan-based awards table. Filing ↗machine: t62 · r3 · c3 · span 1144244–1144250 |
| 22 | Section 07, pay ratio | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “CEO Pay Ratio”. As printed: 163 : 1. Filing ↗machine: span 2373090–2373098 |
| 23 | Section 08, Robert Chapek | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Director Compensation”. As printed: 484,302. Filing ↗machine: t35 · r2 · c29 · span 745381–745388 |
| 24 | Section 08, Craig Reynolds | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Director Compensation”. As printed: 330,408. Filing ↗machine: t35 · r8 · c29 · span 770293–770300 |
| 25 | Section 08, Quentin Koffey | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Director Compensation”. As printed: 300,889. Filing ↗machine: t35 · r5 · c29 · span 757737–757744 |
| 26 | Section 08, Michelle Brennan | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Director Compensation”. As printed: 277,813. Filing ↗machine: t35 · r1 · c29 · span 741201–741208 |
| 27 | Section 08, William Jellison | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Director Compensation”. As printed: 227,886. Filing ↗machine: t35 · r4 · c29 · span 753645–753652 |
| 28 | Section 08, Darlene Solomon | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Director Compensation”. As printed: 226,014. Filing ↗machine: t35 · r10 · c29 · span 778568–778575 |
| 29 | Section 08, Timothy Scannell | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Director Compensation”. As printed: 215,967. Filing ↗machine: t35 · r9 · c29 · span 774501–774508 |
| 30 | Section 08, Wendy Lane | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Director Compensation”. As printed: 215,173. Filing ↗machine: t35 · r6 · c29 · span 761913–761920 |
| 31 | Section 08, Rolf Classon | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Director Compensation”. As printed: 44,792. Filing ↗machine: t35 · r3 · c5 · span 746784–746790 |
| 32 | Section 08, Adam Mikkelson | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Director Compensation”. As printed: 18,150. Filing ↗machine: t35 · r7 · c5 · span 763318–763324 |
| 33 | Section 08, Catherine Szyman | DEF 14A | 2025-03-26 | 0001104659-25-027887 | Section “Director Compensation”. As printed: 0. Filing ↗machine: t35 · r11 · c29 · span 782747–782748 |
| 34 | Section 06, 2025 vote | Form 8-K | 2025-04-30 | 0001104659-25-042485 | Item 5.07 · say-on-pay result. As reported: 88.14% (votes for as printed: 42,464,598). Filing ↗ |
| 35 | Section 06, 2024 vote | Form 8-K | 2024-09-25 | 0000937556-24-000085 | Item 5.07 · say-on-pay result. As reported: 64.87% (votes for as printed: 31,525,446). Filing ↗ |
| 36 | Section 06, 2023 vote | Form 8-K | 2023-06-28 | 0000937556-23-000172 | Item 5.07 · say-on-pay result. As reported: 55.67% (votes for as printed: 25,947,310). Filing ↗ |
| 37 | Section 03b vehicle mix (computed) | Computed | — | computed | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 38 | Section 09b board cost (computed) | Computed | — | computed | Cash 541,594 + equity 1,799,800 + all other 0 = 2,341,394, summed across the director compensation table rows.machine: formula: Σ = 2,341,394 |
| 39 | Align Technology, Inc., Section 10b CEO total | DEF 14A | 2026-04-07 | 0001097149-26-000023 | CEO total compensation as printed in Align Technology, Inc.'s own proxy. As printed: 19,193,988. Filing ↗machine: r2 · c42 · span 933168–933178 |
| 40 | Insulet Corporation, Section 10b CEO total | DEF 14A | 2026-04-06 | 0001140361-26-013333 | CEO total compensation as printed in Insulet Corporation's own proxy. As printed: 18,858,968. Filing ↗machine: t218 · r3 · c25 · span 1028076–1028087 |
| 41 | The Cooper Companies, Section 10b CEO total | DEF 14A | 2026-02-24 | 0001628280-26-011110 | CEO total compensation as printed in The Cooper Companies's own proxy. As printed: 16,051,141. Filing ↗machine: t120 · r3 · c14 · span 744904–744914 |
| 42 | Masimo Corp (subject), Section 10b CEO total | DEF 14A | 2025-03-26 | 0001104659-25-027887 | CEO total compensation as printed in Masimo Corp's own proxy. As printed: 15,932,345. Filing ↗machine: span 1265493–1265503 |
| 43 | Hologic, Inc., Section 10b CEO total | DEF 14A | 2025-01-16 | 0001140361-25-001287 | CEO total compensation as printed in Hologic, Inc.'s own proxy. As printed: 15,819,261. Filing ↗machine: r2 · c25 · span 1549664–1549674 |
| 44 | ResMed, Section 10b CEO total | DEF 14A | 2025-10-02 | 0000943819-25-000079 | CEO total compensation as printed in ResMed's own proxy. As printed: 14,674,543. Filing ↗machine: span 1328668–1328678 |
| 45 | Haemonetics Corp., Section 10b CEO total | DEF 14A | 2026-06-09 | 0000313143-26-000074 | CEO total compensation as printed in Haemonetics Corp.'s own proxy. As printed: 12,044,701. Filing ↗machine: span 718173–718183 |
| 46 | QuidelOrtho, Section 10b CEO total | DEF 14A | 2026-04-27 | 0001906324-26-000018 | CEO total compensation as printed in QuidelOrtho's own proxy. As printed: 11,255,782. Filing ↗machine: r4 · c24 · span 760612–760622 |
| 47 | Teladoc Health, Inc., Section 10b CEO total | DEF 14A | 2026-04-07 | 0001477449-26-000020 | CEO total compensation as printed in Teladoc Health, Inc.'s own proxy. As printed: 11,202,996. Filing ↗machine: t167 · r2 · c16 · span 1057476–1057486 |
| 48 | Integra LifeSciences Holdings Corp., Section 10b CEO total | DEF 14A | 2026-04-06 | 0000917520-26-000015 | CEO total compensation as printed in Integra LifeSciences Holdings Corp.'s own proxy. As printed: 9,375,551. Filing ↗machine: r2 · c30 · span 880204–880213 |
| 49 | DENTSPLY SIRONA, Inc., Section 10b CEO total | DEF 14A | 2026-04-23 | 0000818479-26-000125 | CEO total compensation as printed in DENTSPLY SIRONA, Inc.'s own proxy. As printed: 8,760,139. Filing ↗machine: r5 · c27 · span 1201378–1201387 |
| 50 | LivaNova PLC, Section 10b CEO total | DEF 14A | 2026-04-29 | 0001104659-26-050937 | CEO total compensation as printed in LivaNova PLC's own proxy. As printed: 8,047,217. Filing ↗machine: t117 · r3 · c50 · span 1095329–1095338 |
| 51 | Dexcom, Inc., Section 10b CEO total | DEF 14A | 2026-04-15 | 0001093557-26-000061 | CEO total compensation as printed in Dexcom, Inc.'s own proxy. As printed: 7,985,960. Filing ↗machine: span 940364–940373 |
| 52 | Teleflex, Inc., Section 10b CEO total | DEF 14A | 2026-04-13 | 0000096943-26-000039 | CEO total compensation as printed in Teleflex, Inc.'s own proxy. As printed: 6,732,419. Filing ↗machine: span 558736–558745 |
| 53 | ICU Medical, Inc., Section 10b CEO total | DEF 14A | 2026-04-02 | 0000883984-26-000019 | CEO total compensation as printed in ICU Medical, Inc.'s own proxy. As printed: 6,452,042. Filing ↗machine: r2 · c24 · span 432290–432299 |
| 54 | Globus Medical, Inc., Section 10b CEO total | DEF 14A | 2026-04-24 | 0001628280-26-027196 | CEO total compensation as printed in Globus Medical, Inc.'s own proxy. As printed: 4,400,159. Filing ↗machine: r5 · c21 · span 344690–344699 |
| 55 | Section 10a, LivaNova PLC reciprocity | DEF 14A | — | 0001104659-26-050937 | LivaNova PLC names Masimo Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 56 | Section 10a, ResMed reciprocity | DEF 14A | — | 0000943819-25-000079 | ResMed's most recent proxy was read; its disclosed peer group does not include Masimo Corp. Filing ↗ |
| 57 | Section 10a, Dexcom, Inc. reciprocity | DEF 14A | — | 0001093557-26-000061 | Dexcom, Inc.'s most recent proxy was read; its disclosed peer group does not include Masimo Corp. Filing ↗ |
| 58 | Section 10a, Integra LifeSciences Holdings Corp. reciprocity | DEF 14A | — | 0000917520-26-000015 | Integra LifeSciences Holdings Corp. names Masimo Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 59 | Section 10a, Align Technology, Inc. reciprocity | DEF 14A | — | 0001097149-26-000023 | Align Technology, Inc. names Masimo Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 60 | Section 10a, QuidelOrtho reciprocity | DEF 14A | — | 0001906324-26-000018 | QuidelOrtho names Masimo Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 61 | Section 10a, Insulet Corporation reciprocity | DEF 14A | — | 0001140361-26-013333 | Insulet Corporation names Masimo Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 62 | Section 10a, ICU Medical, Inc. reciprocity | DEF 14A | — | 0000883984-26-000019 | ICU Medical, Inc. names Masimo Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 63 | Section 10a, Teladoc Health, Inc. reciprocity | DEF 14A | — | 0001477449-26-000020 | Teladoc Health, Inc.'s most recent proxy was read; its disclosed peer group does not include Masimo Corp. Filing ↗ |
| 64 | Section 10a, Hologic, Inc. reciprocity | DEF 14A | — | 0001140361-25-001287 | Hologic, Inc.'s most recent proxy was read; its disclosed peer group does not include Masimo Corp. Filing ↗ |
| 65 | Section 10a, Haemonetics Corp. reciprocity | DEF 14A | — | 0000313143-26-000074 | Haemonetics Corp. names Masimo Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 66 | Section 10a, The Cooper Companies reciprocity | DEF 14A | — | 0001628280-26-011110 | The Cooper Companies names Masimo Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 67 | Section 10a, DENTSPLY SIRONA, Inc. reciprocity | DEF 14A | — | 0000818479-26-000125 | DENTSPLY SIRONA, Inc.'s most recent proxy was read; its disclosed peer group does not include Masimo Corp. Filing ↗ |
| 68 | Section 10a, Teleflex, Inc. reciprocity | DEF 14A | — | 0000096943-26-000039 | Teleflex, Inc. names Masimo Corp in its own disclosed peer group (read from its most recent proxy). Filing ↗ |